Keywords: GLP-1, psoriasis, hidradenitis suppurativa, liraglutide, semiglutide Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are highly effective pharmacologic agents for managing type 2 diabetes (T2D) and obesity
The cardiovascular effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action
Monthly Renal Monitoring: Regular GFR and electrolyte checks to detect subtle changes early
At 8mg, the range widened to 17% to 60%, depending heavily on titration speed
In a rat model of DOCA-salt hypertension, vascular mitochondrial ROS production was markedly elevated, accompanied by the activation of other ROS sources
These findings reveal how poor health-seeking behavior, compounded by limited oral health literacy, perpetuates untreated morbidity